On the need for a national radiological response plan in Egypt

Use of radioactive materials and sources is increasing within the Arab Republic of Egypt. With this increase comes a need to prepare for accidents involving these materials. For years there has been an informal agreement between the National Centre for Nuclear Safety and Radiation Control (NCNSRC), one of the four centers operated by the Atomic Energy Agency (AEA), and the Civil Defense Authority (CDA) to cooperate in a radiological emergency. CDA currently has the responsibility for responding to all types of emergencies. The increasing use of radioactive materials and the complexity of the response required by accidents creates a need for a more formal arrangement. In response to the increasing possibility of radiation accidents in or near Egypt, the government is preparing the {ital Egyptian Emergency Response Plan for Radiological Accidents} to coordinate the response efforts of the national agencies. This plan, which is now being finalized, provides information on agency roles and responsibilities during a response. The plan will also provide a basis for initiating training, planning for emergency public information, and developing public education efforts

Exposure of a Dengue Vector to Tea and Its Waste: Survival, Developmental Consequences, and Significance for Pest Management

Dengue mosquitoes are evolving into a broader global public health menace, with relentless outbreaks and the rise in number of Zika virus disease cases as reminders of the continued hazard associated with Aedes vectors. The use of chemical insecticidesthe principal strategy against mosquito vectorshas been greatly impeded due to the development of insecticide resistance and the shrinking spectrum of effective agents. Therefore, there is a pressing need for new chemistries for vector control. Tea contains hundreds of chemicals, and its waste, which has become a growing global environmental problem, is almost as rich in toxicants as green leaves. This paper presents the toxic and sublethal effects of different crude extracts of tea on Aedes albopictus. The survival rates of larvae exposed to tea extracts, especially fresh tea extract (FTE), were markedly lower than those in the control treatment group. In addition to this immediate toxicity against different developmental stages, the extracts tested caused a broad range of sublethal effects. The developmental time was clearly longer in containers with tea, especially in those with young larvae (YL) and FTE. Among the survivors, pupation success was reduced in containers with tea, which also produced low adult emergence rates with increasing tea concentration. The production of eggs tended to be reduced in females derived from the tea treatment groups. These indirect effects of tea extracts on Ae. albopictus exhibited different patterns according to the exposed larval stage. Taken together, these findings indicate that tea and its waste affect most key components of Ae. albopictus vectorial capacity and may be useful for dengue control. Reusing tea waste in vector control could also be a practical solution to the problems associated with its pollution

Physical characteristics and reproductive performance in Aedes (Diptera: Culicidae)

Body size is a physical factor of crucial importance underlying important traits of the reproductive dynamics of both sexes in mosquitoes. Most studies on the influence of body size in mating success of dengue vectors addressed sperm transfer to females and did not consider egg production, a prerequisite for population maintenance; male body size impact on reproduction has attracted little research interest with respect to sterile insect technique. In experiments involving differently sized adults, we examined whether the body size of the mates is a source of variation in reproductive outcome in Aedes aegypti. In the absence of male partners, large females (LF) showed better fecundity than small females (SF). In intraclass mating trials, egg production was much greater in largesized than smallsized pairs. There were comparable fecundities in large females mated with small males and large pairs. [SF•SM] and [SF•LM] pairs showed equivalent fecundity. Nonmating did not result in the production of viable eggs by either small or large females. We also observed that eggs produced by largesized females mated with small males had better hatching success than those from either small or large pairs. Mating between small females and large males resulted in poor egg viability

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Background The European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (FHSC) global registry provides a platform for the global surveillance of familial hypercholesterolaemia through harmonisation and pooling of multinational data. In this study, we aimed to characterise the adult population with heterozygous familial hypercholesterolaemia and described how it is detected and managed globally. Methods Using FHSC global registry data, we did a cross-sectional assessment of adults (aged 18 years or older) with a clinical or genetic diagnosis of probable or definite heterozygous familial hypercholesterolaemia at the time they were entered into the registries. Data were assessed overall and by WHO regions, sex, and index versus non-index cases. Findings Of the 61 612 individuals in the registry, 42 167 adults (21 999 [53·6%] women) from 56 countries were included in the study. Of these, 31 798 (75·4%) were diagnosed with the Dutch Lipid Clinic Network criteria, and 35 490 (84·2%) were from the WHO region of Europe. Median age of participants at entry in the registry was 46·2 years (IQR 34·3–58·0); median age at diagnosis of familial hypercholesterolaemia was 44·4 years (32·5–56·5), with 40·2% of participants younger than 40 years when diagnosed. Prevalence of cardiovascular risk factors increased progressively with age and varied by WHO region. Prevalence of coronary disease was 17·4% (2·1% for stroke and 5·2% for peripheral artery disease), increasing with concentrations of untreated LDL cholesterol, and was about two times lower in women than in men. Among patients receiving lipid-lowering medications, 16 803 (81·1%) were receiving statins and 3691 (21·2%) were on combination therapy, with greater use of more potent lipid-lowering medication in men than in women. Median LDL cholesterol was 5·43 mmol/L (IQR 4·32–6·72) among patients not taking lipid-lowering medications and 4·23 mmol/L (3·20–5·66) among those taking them. Among patients taking lipid-lowering medications, 2·7% had LDL cholesterol lower than 1·8 mmol/L; the use of combination therapy, particularly with three drugs and with proprotein convertase subtilisin–kexin type 9 inhibitors, was associated with a higher proportion and greater odds of having LDL cholesterol lower than 1·8 mmol/L. Compared with index cases, patients who were non-index cases were younger, with lower LDL cholesterol and lower prevalence of cardiovascular risk factors and cardiovascular diseases (all p<0·001). Interpretation Familial hypercholesterolaemia is diagnosed late. Guideline-recommended LDL cholesterol concentrations are infrequently achieved with single-drug therapy. Cardiovascular risk factors and presence of coronary disease were lower among non-index cases, who were diagnosed earlier. Earlier detection and greater use of combination therapies are required to reduce the global burden of familial hypercholesterolaemia. Funding Pfizer, Amgen, Merck Sharp & Dohme, Sanofi–Aventis, Daiichi Sankyo, and Regeneron